GlaxoSmithKline Up 30.2% Since SmarTrend's Buy RecommendationTrading Markets (press release)… News | PowerRating — SmarTrend, our proprietary pattern recognition system, called an Uptrend for GlaxoSmithKline (NYSE:GSK) on May 12, 2009 at $31.94. …Best Buy Up 10.2% Since SmarTrend's Buy RecommendationTrading Markets (press release)Estee Lauder Up 8% Since SmarTrend's Buy RecommendationTrading Markets (press release)Rockwell Collins Up 21.2% Since SmarTrend's Buy RecommendationTrading Markets (press release)Trading Markets (press release) -Trading Markets (press release) -Tr